The Source Blog
Trends in Price and Quality Transparency
All Payer Claims Databases (APCD)
For more on APCD’s, check out our Legislative Topics: All Payer Claims Databases overview on Medium.
Pharmaceutical Price Transparency Legislation
For more on this legislation, refer to our Issue Brief on The Source Blog and the NASHP Center for Rx Pricing.
-
Key:
- Price Transparency Legislation
Recent Action in Price and Quality Transparency
HB 287 – Delaware
Introduced: 2020 Status: In Process
This Act implements recommendations of the Interagency Pharmaceuticals Purchasing Study Group created by House Concurrent Resolution No. 35. First, this Act creates the Interagency Pharmaceutical Purchasing Collaborative (“Collaborative”) to leverage the total volume of State …
HB 286 – Delaware
Introduced: 2020 Status: In Process
This bill requires that inadvertent out-of-network services be included in individual and group health insurance policies as well as group and blank health insurance policies. This bill defines inadvertent out-of-network services are those services that …
SB 303 – Georgia
Introduced: 2020 Status: In Process
‘Georgia Right to Shop Act’; greater transparency of prices for nonemergency healthcare services; provide. Would allow patients to ask their insurance company, either online or on the phone, on what out-of-pocket costs they would face …
SB 293 – Georgia
Introduced: 2020 Status: In Process
Balance Billing Consumer Protection Act. A BILL to be entitled an Act to amend Title 33 of the O.C.G.A., relating to insurance, so as to provide for certain consumer protections against balance billing; to amend …
HB 888 (see companion bill SB 359) – Georgia
Introduced: 2020 Status: In Process
Surprise Billing Consumer Protection Act: A BILL to be entitled an Act to amend Title 33 of the O.C.G.A., relating to insurance, so as to provide for certain consumer protections against surprise billing; to provide …
SB 359 (see companion bill HB 888) – Georgia
Introduced: 2020 Status: In Process
Surprise Billing Consumer Protection Act: A BILL to be entitled an Act to amend Title 33 of the Official Code of Georgia Annotated, relating to insurance, so as to provide for certain consumer protections against …
SB 194 – Delaware
Introduced: 2019 Status: Enacted
Given the scope of PBMs in the healthcare delivery system, this Act is designed to provide enhanced oversight and transparency as it relates PBMs. Specifically, this Act does the following: (1) Requires PBMs to register …
Next | See all Legislation Records
Introduced: 2020 Status: In Process
This Act implements recommendations of the Interagency Pharmaceuticals Purchasing Study Group created by House Concurrent Resolution No. 35. First, this Act creates the Interagency Pharmaceutical Purchasing Collaborative (“Collaborative”) to leverage the total volume of State …
HB 286 – Delaware
Introduced: 2020 Status: In Process
This bill requires that inadvertent out-of-network services be included in individual and group health insurance policies as well as group and blank health insurance policies. This bill defines inadvertent out-of-network services are those services that …
SB 303 – Georgia
Introduced: 2020 Status: In Process
‘Georgia Right to Shop Act’; greater transparency of prices for nonemergency healthcare services; provide. Would allow patients to ask their insurance company, either online or on the phone, on what out-of-pocket costs they would face …
SB 293 – Georgia
Introduced: 2020 Status: In Process
Balance Billing Consumer Protection Act. A BILL to be entitled an Act to amend Title 33 of the O.C.G.A., relating to insurance, so as to provide for certain consumer protections against balance billing; to amend …
HB 888 (see companion bill SB 359) – Georgia
Introduced: 2020 Status: In Process
Surprise Billing Consumer Protection Act: A BILL to be entitled an Act to amend Title 33 of the O.C.G.A., relating to insurance, so as to provide for certain consumer protections against surprise billing; to provide …
SB 359 (see companion bill HB 888) – Georgia
Introduced: 2020 Status: In Process
Surprise Billing Consumer Protection Act: A BILL to be entitled an Act to amend Title 33 of the Official Code of Georgia Annotated, relating to insurance, so as to provide for certain consumer protections against …
SB 194 – Delaware
Introduced: 2019 Status: Enacted
Given the scope of PBMs in the healthcare delivery system, this Act is designed to provide enhanced oversight and transparency as it relates PBMs. Specifically, this Act does the following: (1) Requires PBMs to register …
Next | See all Legislation Records
PhRMA and BIO v. Sandoval – Nevada
District Court: District of Nevada Status: Decided
In September 2017, just three months after Nevada passed its insulin transparency law (SB 539) in June 2017 to increase transparency over the price of …
Pharmaceutical Care Management v. Rutledge – Arkansas
District Court: Eastern District of Arkansas Status: Decided
The 8th Circuit held that both ERISA and Medicare Part D preempted Arkansas’ drug pricing law Act 900 (SB 688). Act 900 requires disclosure of …
PhRMA v. David – California
District Court: Eastern District of California Status: Pending
PhRMA is challenging California’s drug price transparency law SB 17 alleging that the law is unconstitutional because it violates the Commerce Clause, the First Amendment, …
Association for Accessible Medicines v. Frosh – Maryland
District Court: District of Maryland Status: Decided
In a significant victory for the pharmaceutical industry, the 4th U.S. Circuit Court of Appeals found Maryland’s landmark 2017 law (HB 631), which punishes generic …
See all Litigation Records
District Court: District of Nevada Status: Decided
In September 2017, just three months after Nevada passed its insulin transparency law (SB 539) in June 2017 to increase transparency over the price of …
Pharmaceutical Care Management v. Rutledge – Arkansas
District Court: Eastern District of Arkansas Status: Decided
The 8th Circuit held that both ERISA and Medicare Part D preempted Arkansas’ drug pricing law Act 900 (SB 688). Act 900 requires disclosure of …
PhRMA v. David – California
District Court: Eastern District of California Status: Pending
PhRMA is challenging California’s drug price transparency law SB 17 alleging that the law is unconstitutional because it violates the Commerce Clause, the First Amendment, …
Association for Accessible Medicines v. Frosh – Maryland
District Court: District of Maryland Status: Decided
In a significant victory for the pharmaceutical industry, the 4th U.S. Circuit Court of Appeals found Maryland’s landmark 2017 law (HB 631), which punishes generic …
See all Litigation Records
News & Opinions
Articles & Reports
OSHPD
March 9, 2020
JAMA March 9, 2020
Journal of Medical Systems March 5, 2020
NCMJ March 5, 2020
JAMA March 9, 2020
Journal of Medical Systems March 5, 2020
NCMJ March 5, 2020
If you would like to report a possible data discrepancy, please email info@sourceonhealthcare.org or contact The Source here.